3Tavassoli F A, Devilee P. World Health Organization classification of tumors, pathology and genetics, tumors of the breast and female genital organ [ M ]. Lyon : IARC Press, 2003 : 140 - 3.
4Logani S, Oliva E, Amin M B, et al. Immunoprofile of ovarian tumors with putative transitional cell (urothelial) differentiation u- sing novel urothelial markers: histogenetic and diagnostic implica- tions[J]. Am J Surg Pathol, 2003,27( 11 ) :1434 -41.
5Eichhorn J H, Young R H. Transitional cell carcinoma of the ova- ry: a morphologic study of 100 cases with emphasis on differential diagnosis[J]. Am J Surg Pathol, 2004,28(4) :453 -63.
6Ben Aissia N, Sadfi A, Youssef A, et al. Malign Brenner's tumor particularities and coverage [ J ]. Tunis Med, 2004,82 ( 7 ) : 701 -7.
7Akman L, Akdemir A, Terek M C, et al. Ovarian malignant Bren- ner tumor in patients over 65 years of age [ J ]. Kaohsiung J Med Sei, 2014,30(3) :159 -60.
8Kondi-Pafiti A, Kairi-Vassilatou E, Iavazzo C H, et al. Clinico- pathological features and immunoprofile of 30 cases of Brenner o- varian tumors [ J ]. Arch Gynecol Obstet, 2012,285 (6) : 1699 - 702.
9Houghton O, McCluggage W G. The expression and diagnostic util- ity of p63 in the female genital tract[J]. Adv Anat Pathol, 2009, 16(5) :316 -21.
10Cuatrecasas M, Catasus L, Palacios J, et al. Transitional cell tumors of the ovary : a comparative clinicopathologic, immunohisto- chemical and molecular genetic analysis of Brenner tumors and transitional cell carcinomas [ J ]. Am J Surg Pathol, 2009,33 (4) : 556 - 67.
